Philip Morris International (Philip Morris International) Risk Assessment

View and export this data going back to 2008. Start your Free Trial

What is Philip Morris International Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Philip Morris International is: Moderate Risk: Sensitive, better choose undervalued stock.

Competitive Comparison of Philip Morris International's Risk Assessment

For the Tobacco subindustry, Philip Morris International's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Philip Morris International's Risk Assessment Distribution in the Tobacco Products Industry

For the Tobacco Products industry and Consumer Defensive sector, Philip Morris International's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Philip Morris International's Risk Assessment falls into.

Philip Morris International (NYSE:PM) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Philip Morris International Risk Assessment Related Terms

Thank you for viewing the detailed overview of Philip Morris International's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Philip Morris International (Philip Morris International) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Tobacco Products » Philip Morris International Inc (NYSE:PM) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

PM:Mexico 1PM:Italy 0M8V:UK 4I1:Germany 4I1:Germany 4I1:Germany PMI:Switzerland PHMO34:Brazil PMOR:Austria

Address

677 Washington Boulevard, Suite 1100, Stamford, Connecticut, New York, NY, USA, 06901

Website

https://www.pmi.com

Philip Morris International is an international tobacco company with a product portfolio primarily consisting of cigarettes and reduced-risk products, including heat-not-burn, vapor and oral nicotine products, which are sold in markets outside the United States. The company diversified away from cigarettes with the 2022 acquisition of Swedish Match, a leading manufacturer of traditional oral tobacco products and nicotine pouches, primarily in the U.S. and Scandinavia. It diversified away from nicotine products with the acquisition of Vectura, a provider of innovative inhaled drug delivery solutions, in 2021.

Executives

Wilde Frederic De	officer: Sr. VP, Marketing & Sales	120 PARK AVENUE, NEW YORK NY 10017
Yann Guerin	officer: SVP & Global Head of L&C	677 WASHINGTON BLVD., SUITE 1100, STAMFORD CT 06901
Werner Barth	officer: Sr. VP, Marketing and Sales	120 PARK AVENUE, NEW YORK NY 10017
Lars Dahlgren	officer: Pres. Smoke-Free Oral Products	677 WASHINGTON BLVD., STAMFORD CT 06896
Dessislava Temperley	director	C/O CIMPRESS PLC, 275 WYMAN STREET, WALTHAM MA 02451
Reginaldo Dobrowolski	officer: Vice President and Controller	677 WASHINGTON BLVD, SUITE 1100, STAMFORD CT 06901
Martin G. King	officer: SVP Operations	120 PARK AVENUE, NEW YORK NY 10017
Paul Riley	officer: Pres East Asia & Australia	120 PARK AVENUE, NEW YORK NY 10017
Drago Azinovic	officer: Pres., European Union Region	120 PARK AVENUE, NEW YORK NY 10017
Mario Masseroli	officer: Pres., Latin America & Canada	120 PARK AVENUE, NEW YORK NY 10017
Juan J. Daboub	director	5100 W. 115TH PLACE, LEAWOOD KS 66211
Shlomo Yanai	director	ONE MEADOWLANDS PLAZA, EAST RUTHERFORD NJ 07073
Stacey Kennedy	officer: Pres. South & Southeast Asia	120 PARK AVENUE, NEW YORK NY 10017
Charles Bendotti	officer: Senior VP, Human Resources	120 PARK AVENUE, NEW YORK NY 10017
Andre Calantzopoulos	director, officer: President & CEO	677 WASHINGTON BLVD, SUITE 1100, STAMFORD CT 06901